-
Notifications
You must be signed in to change notification settings - Fork 0
Commit
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
- Loading branch information
Showing
1 changed file
with
24 additions
and
0 deletions.
There are no files selected for viewing
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -0,0 +1,24 @@ | ||
# ENEO | ||
|
||
[![Snakemake](https://img.shields.io/badge/snakemake-≥6.1.0-brightgreen.svg)](https://snakemake.github.io) | ||
[![Linting](https://github.com/ctglab/ENEO/actions/workflows/formatting.yml/badge.svg?branch=main)](https://github.com/ctglab/ENEO/actions/workflows/formatting.yml) | ||
[![Conventional Commits](https://img.shields.io/badge/Conventional%20Commits-1.0.0-%23FE5196?logo=conventionalcommits&logoColor=white)](https://conventionalcommits.org) | ||
|
||
|
||
ENEO (pronunced `/eˈnɛjo/`) is a Snakemake workflow developed for detecting immunogenic neoantigens arising from somatic mutations using only bulk tumor RNA-seq, without requiring matching samples or additional genomic data (WES/WGS). It uses a probabilistic model that leverages population genetics databases and genotype likelihoods to discriminate germline variants from the call set. Additional details are reported in the [bioRxiv preprint](https://www.biorxiv.org/content/10.1101/2024.08.08.607127v1). | ||
|
||
## Usage | ||
|
||
Pipeline documentation is available at [https://ctglab.github.io/ENEO](https://ctglab.github.io/ENEO) | ||
|
||
## Cite | ||
|
||
If you used this workflow in your work, don't forget to give credit to the authors by citing the original publication | ||
|
||
>Tatoni, D., Dalsass, M., Brunelli, G., Grandi, G., Chiariello, M., & D'Aurizio, R. (2024). Efficient and effective identification of cancer neoantigens from tumor only RNA-seq. bioRxiv, 2024-08. | ||
|
||
|
||
|
||
|
||
|